DACLERAD Trademark

Trademark Overview

On Friday, January 18, 2013, a trademark application was filed for DACLERAD with the United States Patent and Trademark Office. The USPTO has given the DACLERAD trademark a serial number of 85826966. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 15, 2016. This trademark is owned by Bristol-Myers Squibb Company. The DACLERAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
daclerad

General Information

Serial Number85826966
Word MarkDACLERAD
Filing DateFriday, January 18, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 15, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Translation of Words in MarkThe wording "DACLERAD" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 24, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Tuesday, February 16, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 15, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, July 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 9, 2015EXTENSION 3 GRANTED
Friday, June 26, 2015EXTENSION 3 FILED
Thursday, July 9, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 26, 2015TEAS EXTENSION RECEIVED
Saturday, February 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 20, 2015EXTENSION 2 GRANTED
Monday, January 5, 2015EXTENSION 2 FILED
Tuesday, February 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 5, 2015TEAS EXTENSION RECEIVED
Wednesday, July 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2014EXTENSION 1 GRANTED
Monday, June 30, 2014EXTENSION 1 FILED
Monday, June 30, 2014TEAS EXTENSION RECEIVED
Tuesday, January 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 17, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 17, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 16, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2013ASSIGNED TO LIE
Monday, October 14, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 1, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2013NON-FINAL ACTION E-MAILED
Wednesday, May 1, 2013NON-FINAL ACTION WRITTEN
Wednesday, May 1, 2013ASSIGNED TO EXAMINER
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 24, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 22, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

daclerad diseases pharmaceutical human anti preparations disorders organ solid auto immune